1. Product Introduction:
Ibscim Tablet contains Imatinib Mesylate, a tyrosine kinase inhibitor that blocks specific proteins involved in the growth of cancer cells. It is an oral anticancer medication used to manage conditions such as chronic myeloid leukemia and gastrointestinal stromal tumors.
2. Uses:
-
Chronic Myeloid Leukemia (CML)
-
Gastrointestinal Stromal Tumors (GIST)
-
Other cancers involving abnormal tyrosine kinase activity
3. Benefit:
-
Targets cancer cell growth pathways
-
Helps achieve remission in CML patients
-
Reduces tumor size and progression in GIST
-
Oral administration allows outpatient treatment
4. Composition:
Each tablet contains:
-
Imatinib Mesylate 50 mg
5. Side Effects:
Common side effects include:
-
Nausea and vomiting
-
Fatigue and weakness
-
Muscle cramps
-
Diarrhea
-
Skin rash
Serious side effects require immediate medical attention, including liver problems, severe fluid retention, or infections.
6. Safety Advice:
-
Take exactly as prescribed by your oncologist.
-
Do not stop therapy without medical advice.
-
Regular monitoring of blood counts and liver function is essential.
-
Inform your doctor about all medications and supplements you take.
-
Avoid grapefruit juice and certain medications that interact with Imatinib.
